Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
GSK256066 is a potent and selective PDE4 inhibitor that can be given by inhalation
CC(=O)NC1=CC(=CC2=CC(=C(N=NC3C=CC=CC=3)C(O)=C21)S([O-])(=O)=O)S([O-])(=O)=O
Formula: C6H12ClNO2
Serum aspartate transaminase (AST) and alanine transaminase (ALT) levels are significantly lowered in the Adenosine 5'-monophosphate monohydrate group than in the vehicle group
20)/b15-13-
3'-Hydroxy Repaglinide Catalog No.:M23864-C GSK256066 is a potent and3' Hydroxy Repaglinide is a main CYP2C8 metabolite of Repaglinide. Repaglinide is a carbamoylmethyl benzoic acid (CMBA) derivative, which recently has become available for the treatment of type II diabetes. Product information CAS Number: 874908 14 2 Molecular Weight: 468. 59 Formula: C27H36N2O5 Chemical Name: 2 ethoxy 4 [({1 [2 (3 hydroxypiperidin 1 yl)phenyl] 3 methylbutyl}carbamoyl)methyl]benzoic acid Smiles:
US$ 2749.00
US$ 17900.00
US$ 1475.00
US$ 10.99
US$ 1475.00
US$ 1000.00
US$ 499500.00
US$ 1097.00
US$ 1687.00
US$ 22500.00
US$ 1475.00
US$ 22750.00
US$ 1475.00